# BALL Corp: financial statements, quarterly

BALL · NYSE · CIK 9389 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ball.md) · [Financials](/companies/ball/financials.md) · [Filings](/companies/ball/filings.md) · [Insiders](/companies/ball/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ball/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,111](/filings/0001558370-25-001190.md) | [2,903](/filings/0001558370-25-001190.md) | [2,874](/filings/0001558370-25-006439.md) | [2,959](/filings/0001558370-25-010234.md) | [3,082](/filings/0001104659-25-106108.md) | [2,880](/filings/0001558370-25-001190.md) | [3,097](/filings/0001104659-26-055460.md) | [3,338](/filings/0001104659-26-090226.md) | [3,379](/filings/0001104659-25-106108.md) | [3,347 d](/filings/0001104659-26-017410.md) | [3,603](/filings/0001104659-26-055460.md) | [3,997](/filings/0001104659-26-090226.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | [487](/filings/0001558370-25-001190.md) | [483](/filings/0001558370-25-001190.md) | [477](/filings/0001558370-25-001190.md) | [489](/filings/0001558370-25-001190.md) | [545](/filings/0001558370-25-001190.md) | [480](/filings/0001558370-25-001190.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [133](/filings/0001558370-24-014033.md) | [123 d](/filings/0001104659-26-017410.md) | [237](/filings/0001558370-25-006439.md) | [139](/filings/0001558370-25-010234.md) | [142](/filings/0001104659-25-106108.md) | [129 d](/filings/0001104659-26-017410.md) | [149](/filings/0001104659-26-055460.md) | [137](/filings/0001104659-26-090226.md) | [130](/filings/0001104659-25-106108.md) | [150 d](/filings/0001104659-26-017410.md) | [150](/filings/0001104659-26-055460.md) | [163](/filings/0001104659-26-090226.md) |
| Operating income | $m | [325](/filings/0001558370-23-017394.md) | [300 d](/filings/0001558370-24-001349.md) | [196](/filings/0001558370-24-006975.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [45.0](/filings/0001558370-24-014033.md) | [39.0 d](/filings/0001104659-26-017410.md) | [27.0](/filings/0001558370-25-006439.md) | [49.0](/filings/0001558370-25-010234.md) | [42.0](/filings/0001104659-25-106108.md) | [15.0 d](/filings/0001104659-26-017410.md) | [53.0](/filings/0001104659-26-055460.md) | [61.0](/filings/0001104659-26-090226.md) | [76.0](/filings/0001104659-25-106108.md) | [50.0 d](/filings/0001104659-26-017410.md) | [62.0](/filings/0001104659-26-055460.md) | [65.0](/filings/0001104659-26-090226.md) |
| Net income | $m | [204](/filings/0001558370-25-001190.md) | [154](/filings/0001558370-25-001190.md) | [3,686](/filings/0001558370-25-006439.md) | [159](/filings/0001558370-25-010234.md) | [199](/filings/0001104659-25-106108.md) | [(30.0)](/filings/0001558370-25-001190.md) | [179](/filings/0001104659-26-055460.md) | [215](/filings/0001104659-26-090226.md) | [321](/filings/0001104659-25-106108.md) | [200 d](/filings/0001104659-26-017410.md) | [205](/filings/0001104659-26-055460.md) | [223](/filings/0001104659-26-090226.md) |
| Diluted EPS | $ per share | [0.64](/filings/0001558370-25-001190.md) | [0.49](/filings/0001558370-25-001190.md) | [11.61](/filings/0001558370-25-006439.md) | [0.51](/filings/0001558370-25-010234.md) | [0.65](/filings/0001104659-25-106108.md) | [(0.11)](/filings/0001558370-25-001190.md) | [0.63](/filings/0001104659-26-055460.md) | [0.76](/filings/0001104659-26-090226.md) | [1.18](/filings/0001104659-25-106108.md) | not reported | [0.77](/filings/0001104659-26-055460.md) | [0.83](/filings/0001104659-26-090226.md) |
| Basic EPS | $ per share | [0.64](/filings/0001558370-25-001190.md) | [0.49](/filings/0001558370-25-001190.md) | [11.70](/filings/0001558370-25-006439.md) | [0.51](/filings/0001558370-25-010234.md) | [0.65](/filings/0001104659-25-106108.md) | [(0.11)](/filings/0001558370-25-001190.md) | [0.63](/filings/0001104659-26-055460.md) | [0.77](/filings/0001104659-26-090226.md) | [1.18](/filings/0001104659-25-106108.md) | not reported | [0.77](/filings/0001104659-26-055460.md) | [0.83](/filings/0001104659-26-090226.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: not reported
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1.3](/filings/0001558370-24-014033.md) | [0.7](/filings/0001104659-26-017410.md) | [1.7](/filings/0001558370-25-006439.md) | [1.3](/filings/0001558370-25-010234.md) | [1.4](/filings/0001104659-25-106108.md) | [0.9](/filings/0001104659-26-090226.md) | [0.4](/filings/0001104659-26-055460.md) | [0.3](/filings/0001104659-26-090226.md) | [0.6](/filings/0001104659-25-106108.md) | [1.2](/filings/0001104659-26-090226.md) | [0.7](/filings/0001104659-26-055460.md) | [0.5](/filings/0001104659-26-090226.md) |
| Current assets | $bn | [5.4](/filings/0001558370-23-017394.md) | [4.9](/filings/0001558370-25-001190.md) | [6.5](/filings/0001558370-24-006975.md) | [5.8](/filings/0001558370-24-010565.md) | [5.6](/filings/0001558370-24-014033.md) | [4.8](/filings/0001104659-26-017410.md) | [5.0](/filings/0001558370-25-006439.md) | [5.3](/filings/0001558370-25-010234.md) | [5.3](/filings/0001104659-25-106108.md) | [6.1](/filings/0001104659-26-090226.md) | [6.2](/filings/0001104659-26-055460.md) | [6.7](/filings/0001104659-26-090226.md) |
| Total assets | $bn | [19.9](/filings/0001558370-23-017394.md) | [19.3](/filings/0001558370-25-001190.md) | [19.9](/filings/0001558370-24-006975.md) | [19.0](/filings/0001558370-24-010565.md) | [18.8](/filings/0001558370-24-014033.md) | [17.6](/filings/0001104659-26-017410.md) | [18.0](/filings/0001558370-25-006439.md) | [18.6](/filings/0001558370-25-010234.md) | [18.7](/filings/0001104659-25-106108.md) | [19.5](/filings/0001104659-26-090226.md) | [19.8](/filings/0001104659-26-055460.md) | [20.1](/filings/0001104659-26-090226.md) |
| Current liabilities | $bn | [6.7](/filings/0001558370-23-017394.md) | [6.2](/filings/0001558370-25-001190.md) | [5.4](/filings/0001558370-24-006975.md) | [4.9](/filings/0001558370-24-010565.md) | [5.1](/filings/0001558370-24-014033.md) | [4.8](/filings/0001104659-26-017410.md) | [4.8](/filings/0001558370-25-006439.md) | [5.3](/filings/0001558370-25-010234.md) | [4.8](/filings/0001104659-25-106108.md) | [5.5](/filings/0001104659-26-090226.md) | [5.6](/filings/0001104659-26-055460.md) | [6.2](/filings/0001104659-26-090226.md) |
| Total liabilities | $bn | [15.9](/filings/0001558370-23-017394.md) | [15.5](/filings/0001558370-25-001190.md) | [12.5](/filings/0001558370-24-006975.md) | [12.0](/filings/0001558370-24-010565.md) | [12.1](/filings/0001558370-24-014033.md) | [11.7](/filings/0001104659-26-017410.md) | [12.5](/filings/0001558370-25-006439.md) | [13.3](/filings/0001558370-25-010234.md) | [13.3](/filings/0001104659-25-106108.md) | [14.1](/filings/0001104659-26-090226.md) | [14.2](/filings/0001104659-26-055460.md) | [14.3](/filings/0001104659-26-090226.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $bn | [2.1](/filings/0001558370-23-017394.md) | [0.9](/filings/0001558370-25-001190.md) | [0.3](/filings/0001558370-24-006975.md) | [0.3](/filings/0001558370-24-010565.md) | [0.5](/filings/0001558370-24-014033.md) | [0.2](/filings/0001104659-26-017410.md) | [0.4](/filings/0001558370-25-006439.md) | [0.4](/filings/0001558370-25-010234.md) | [0.3](/filings/0001104659-25-106108.md) | [0.0](/filings/0001104659-26-090226.md) | [0.6](/filings/0001104659-26-055460.md) | [0.6](/filings/0001104659-26-090226.md) |
| Shareholders' equity | $bn | [3.9](/filings/0001558370-23-017394.md) | [3.8](/filings/0001558370-25-001190.md) | [7.3](/filings/0001558370-24-006975.md) | [6.9](/filings/0001558370-24-010565.md) | [6.7](/filings/0001558370-24-014033.md) | [5.9](/filings/0001104659-26-017410.md) | [5.5](/filings/0001558370-25-006439.md) | [5.2](/filings/0001558370-25-010234.md) | [5.4](/filings/0001104659-25-106108.md) | [5.4](/filings/0001104659-26-090226.md) | [5.6](/filings/0001104659-26-055460.md) | [5.7](/filings/0001104659-26-090226.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: us-gaap:DebtCurrent, us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [766 d](/filings/0001558370-24-014033.md) | [736 d](/filings/0001104659-26-017410.md) | [(1,247)](/filings/0001558370-25-006439.md) | [252 d](/filings/0001558370-25-010234.md) | [610 d](/filings/0001104659-25-106108.md) | [500 d](/filings/0001104659-26-017410.md) | [(665)](/filings/0001104659-26-055460.md) | [332 d](/filings/0001104659-26-090226.md) | [384 d](/filings/0001104659-25-106108.md) | [1,211 d](/filings/0001104659-26-017410.md) | [(777)](/filings/0001104659-26-055460.md) | [608 d](/filings/0001104659-26-090226.md) |
| Capital expenditure | $m | [222 d](/filings/0001558370-24-014033.md) | [215 d](/filings/0001104659-26-017410.md) | [154](/filings/0001558370-25-006439.md) | [106 d](/filings/0001558370-25-010234.md) | [117 d](/filings/0001104659-25-106108.md) | [107 d](/filings/0001104659-26-017410.md) | [81.0](/filings/0001104659-26-055460.md) | [96.0 d](/filings/0001104659-26-090226.md) | [127 d](/filings/0001104659-25-106108.md) | [170 d](/filings/0001104659-26-017410.md) | [161](/filings/0001104659-26-055460.md) | [141 d](/filings/0001104659-26-090226.md) |
| Dividends paid | $m | [63.0 d](/filings/0001558370-24-014033.md) | [63.0 d](/filings/0001104659-26-017410.md) | [63.0](/filings/0001558370-25-006439.md) | [62.0 d](/filings/0001558370-25-010234.md) | [60.0 d](/filings/0001104659-25-106108.md) | [59.0 d](/filings/0001104659-26-017410.md) | [57.0](/filings/0001104659-26-055460.md) | [55.0 d](/filings/0001104659-26-090226.md) | [54.0 d](/filings/0001104659-25-106108.md) | [54.0 d](/filings/0001104659-26-017410.md) | [54.0](/filings/0001104659-26-055460.md) | [53.0 d](/filings/0001104659-26-090226.md) |
| Share repurchases | $m | [0.0 d](/filings/0001558370-24-014033.md) | [0.0 d](/filings/0001104659-26-017410.md) | [182](/filings/0001558370-25-006439.md) | [483 d](/filings/0001558370-25-010234.md) | [396 d](/filings/0001104659-25-106108.md) | [651 d](/filings/0001104659-26-017410.md) | [555](/filings/0001104659-26-055460.md) | [467 d](/filings/0001104659-26-090226.md) | [84.0 d](/filings/0001104659-25-106108.md) | [215 d](/filings/0001104659-26-017410.md) | [1.0](/filings/0001104659-26-055460.md) | [114 d](/filings/0001104659-26-090226.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [317](/filings/0001558370-23-017394.md) | [317](/filings/0001558370-24-006975.md) | [317](/filings/0001558370-24-010565.md) | [317](/filings/0001558370-24-014033.md) | [317](/filings/0001558370-25-006439.md) | [312](/filings/0001558370-25-010234.md) | [305](/filings/0001104659-25-106108.md) | [285](/filings/0001104659-26-055460.md) | [278](/filings/0001104659-26-090226.md) | [273](/filings/0001104659-25-106108.md) | [267](/filings/0001104659-26-055460.md) | [267](/filings/0001104659-26-090226.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 264,703,357 at 2026-07-31, from the cover of the [10-Q filed 2026-08-04](/filings/0001104659-26-090226.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:17 ET. No prices; not investment advice.